Related Experiment Video
Updated: Aug 18, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray
Yang Liu1, Hui Peng, Jian-Ting Zhang
1IU Cancer Center, Indiana University School of Medicine, 1044 W. Walnut Street, R4-166, Indianapolis, IN 46202, USA.
Abstract:
ATP-binding cassette (ABC) membrane proteins comprise a superfamily of transporters with a wide variety of substrates. Humans have 49 members in this superfamily. Several human ABC transporters, such as ABCB1 and ABCC1, have been attributed to cause multidrug resistance (MDR) in cancer treatment when over-expressed. In the past, an MDR cancer cell line MCF7/AdVp3000 has been selected, and overexpression of ABCG2 was thought to cause MDR in this cell line. However, ectopic overexpression of ABCG2 in MCF7 cells could not explain the high drug resistance level observed with the selected cell line. In this study, we designed an AmpArray analysis to profile whether other ABC transporters were also selected to contribute to the increased drug resistance in MCF7/AdVp3000 cells. We found that 16 ABC transporters, including ABCG2, had >/=1.5-fold altered expression in MCF7/AdVp3000 compared with the parental MCF7 cells. In particular, the expression of ABCA4 and ABCC3 was increased by 132- and 459-fold, respectively, whereas ABCG2 was increased by approximately 3000-fold. Furthermore, the elevated expression of these three transporters reversed with the reversed drug resistance phenotype, and silencing ABCC3 expression in MCF7/AdVp3000 cells significantly reduced doxorubicin resistance. Thus, other ABC transporters in addition to ABCG2 are likely to contribute to the MDR selected in MCF7/AdVp3000 cells. This study also shows that AmpArray can be used as a quick and easy tool to profile the expression of ABC transporters in resistant cell lines and tumor samples for potential use in individualized design of therapy.
Insights
Multidrug resistance (MDR) in cancer involves more than just ABCG2. This study found other ATP-binding cassette (ABC) transporters, like ABCA4 and ABCC3, also contribute to MDR in MCF7/AdVp3000 cells, suggesting new therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- ATP-binding cassette (ABC) transporters are a superfamily of membrane proteins involved in transporting various substrates.
- Overexpression of certain human ABC transporters, such as ABCB1 and ABCC1, is linked to multidrug resistance (MDR) in cancer chemotherapy.
- Previous research suggested ABCG2 overexpression caused MDR in the MCF7/AdVp3000 cell line, but this alone did not fully explain the observed resistance levels.
Purpose of the Study:
- To investigate the comprehensive expression profile of ABC transporters in the multidrug-resistant MCF7/AdVp3000 cell line.
- To identify other ABC transporters, beyond ABCG2, that may contribute to the MDR phenotype in this cell line.
- To evaluate the utility of AmpArray analysis for profiling ABC transporter expression in resistant cell lines and tumors.
Main Methods:
- Utilized AmpArray analysis to profile the expression of ABC transporters in MCF7/AdVp3000 cells compared to parental MCF7 cells.
- Quantified fold-changes in expression for individual ABC transporters.
- Performed gene silencing of ABCC3 in MCF7/AdVp3000 cells to assess its impact on doxorubicin resistance.
Main Results:
- AmpArray analysis revealed altered expression in 16 ABC transporters in MCF7/AdVp3000 cells compared to MCF7 cells (fold-change ≥ 1.5).
- Significant increases in expression were observed for ABCA4 (132-fold), ABCC3 (459-fold), and ABCG2 (~3000-fold).
- Silencing ABCC3 expression in MCF7/AdVp3000 cells led to a significant reduction in doxorubicin resistance, and elevated expression of these transporters reversed with the drug resistance phenotype.
Conclusions:
- Multidrug resistance in MCF7/AdVp3000 cells is likely mediated by the concerted action of multiple ABC transporters, including ABCA4 and ABCC3, in addition to ABCG2.
- The findings suggest that targeting multiple ABC transporters may be a viable strategy for overcoming MDR in cancer.
- AmpArray analysis is presented as an efficient tool for profiling ABC transporter expression, aiding in the potential for individualized cancer therapy design.
Related Concept Videos
ABC Transporters: Exporter
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...